Kabirpanthi Vikrant, Gupta Vikas, Singh Ajit
Department of Community Medicine, Government Medical College, Shahdol, Madhya Pradesh, India.
Department of Pathology, Kalpana Chawla Government Medical College, Karnal, Haryana, India.
J Family Med Prim Care. 2022 Oct;11(10):6042-6048. doi: 10.4103/jfmpc.jfmpc_138_22. Epub 2022 Oct 31.
Reports describing demographics, clinical characteristics, hospital course, morbidity, and mortality in patients in the Indian setting have been published, but they are based on limited numbers of cases. The present study among the patients with known outcomes enabled us to better understand the disease process and progression of COVID-19 cases and to correlate the factors affecting the outcome.
This was a record-based, retrospective observational study of patients admitted to COVID-19 Hospital. We have retrieved medical records for all the hospitalized patients with a laboratory confirmed COVID-19 diagnosis with a known outcome (discharged or died) between April 1, 2020 and February 28, 2021. The extracted data included basic demographics, signs and symptoms, duration of hospitalization, and laboratory parameters. Categorical variables were analysed using either the chisquare test or Fisher's exact test. The level of significance was set at < 0.05.
The mean age of severe and moderate patients was 38.71 years, compared to 34.95 years for mild patients. No gender difference was observed for the severe/moderate, and mild cases. The mortality rate among severe/moderate cases was 11.6%, whereas it was 3.9% in mild patients. Laboratory parameters which were significantly (p < 0.05) raised among the dead compared to discharged patients included CT score, D-dimer, CRP, ALT, AST, and alkaline phosphatase.
Clinical and laboratory characteristics reflect the pathophysiology of disease and thus help clinicians recognise the severity of medical illness. They also facilitate the creation of management protocols for clinical care that results in improvement in patient related outcomes.
描述印度患者人口统计学、临床特征、住院病程、发病率和死亡率的报告已经发表,但这些报告所基于的病例数量有限。本研究针对已知结局的患者,使我们能够更好地了解COVID-19病例的疾病过程和进展,并关联影响结局的因素。
这是一项基于记录的对COVID-19医院收治患者的回顾性观察研究。我们检索了2020年4月1日至2021年2月28日期间所有实验室确诊为COVID-19且结局已知(出院或死亡)的住院患者的病历。提取的数据包括基本人口统计学信息、体征和症状、住院时间以及实验室参数。分类变量使用卡方检验或Fisher精确检验进行分析。显著性水平设定为<0.05。
重症和中症患者的平均年龄为38.71岁,轻症患者为34.95岁。重症/中症和轻症病例未观察到性别差异。重症/中症病例的死亡率为11.6%,而轻症患者为3.9%。与出院患者相比,死亡患者中显著升高(p<0.05)的实验室参数包括CT评分、D-二聚体、CRP、ALT、AST和碱性磷酸酶。
临床和实验室特征反映了疾病的病理生理学,从而有助于临床医生识别疾病的严重程度。它们还有助于制定临床护理管理方案,从而改善患者相关结局。